Clinical Trial Update: The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating PET imaging with [18F]PMPBB3 and [18F]THK5351 to understand distribution patterns related to post-stroke cognitive impairme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroinflammation
• Post-stroke Cognitive Impairment

Drugs mentioned

• [18F]PMPBB3 (null)
• [18F]THK5351 (null)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Post-stroke Cognitive Impairment, Neuroinflammation | Phase 2 | Status: UNKNOWN